[ Back to EurekAlert! ] Public release date: 4-Feb-2013
[ | E-mail Share Share ]

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology

FASEB SRC announces conference registration open for: NAD Metabolism & Signaling

Bethesda, MD – The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): NAD Metabolism & Signaling.

In recent years, it has become increasingly clear that NAD and related metabolites are involved in a wide variety of critical biological processes and pathophysiology of various diseases, including type 2 diabetes and other metabolic complications. In the past decade, many unanticipated, exciting discoveries have been made in the field of NAD biology: new NAD-dependent reactions have been discovered (e.g. NAD-dependent protein deacylation by sirtuins), new enzymes and metabolites have been identified (e.g. nicotinamide phosphoribosyltransferase (NAMPT), nicotinamide riboside kinase (NRK), and O-acetyl-ADP-ribose), new NAD biosynthetic pathways have been revealed (e.g. a new pathway starting from nicotinamide riboside), and new intra- and extracellular NAD-dependent signaling pathways have been characterized (e.g. the NAADP signaling pathway, and NAD-induced cell death of immune cells).

These new discoveries have obviously fueled much more enthusiasm on NAD biology to the scientific community than ever, and classic paradigms, in which NAD/NADH and NADP/NADPH are considered just as co-enzymes, are now quickly being transformed into a novel, more comprehensive view of NAD biology. Indeed, reflecting this exciting trend, the number of publications on NAD biology has dramatically increased in these years. The newly developing areas of NAD biology require extensive, interdisciplinary interactions among scientists with diverse expertise including enzymology, structural biology, medicinal/biological chemistry, cell biology, physiology, genetics, many omics, and translational medicine. Therefore, it is essential to bring those scientists together to a comprehensive, interdisciplinarily organized meeting and fully discuss these cutting-edge fronts of NAD biology for better understanding of their pathophysiological significance. The 2013 FASEB SRC on "NAD Metabolism & Signaling", which started first in Carefree, AZ in 2009, will aim to cover all cutting-edge fronts of NAD biology and provide a great opportunity to nurture further synergism among attendees from many different fields and stimulate interdisciplinary collaborative efforts.

FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.

###

Since 1982, FASEB SRC has offered a continuing series of inter-disciplinary exchanges that are recognized as a valuable complement to the highly successful society meetings. Divided into small groups, scientists from around the world meet intimately and without distractions to explore new approaches to those research areas undergoing rapid scientific changes. In efforts to expand the SRC series, potential organizers are encouraged to contact SRC staff at SRC@faseb.org. Proposal guidelines can be found at www.faseb.org/SRC.

FASEB is composed of 26 societies with more than 100,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB enhances the ability of scientists and engineers to improve—through their research—the health, well-being and productivity of all people. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.



[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.